Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move | Fierce Pharma
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
News & Media
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Reports First Quarter 2020 Financial Results | Business Wire
Global Biosimilar Hormones Market 2021, Industry Trends,
News & Media
Teva Reports Third Quarter 2021 Financial Results
Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia | Business Wire
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Smart Inhalers Market See Huge Growth for New Norm Featuring Teva
Teva Pharmaceutical Industries Limited (TEVA) - Faruqi & Faruqi LLP
New branded drugs helping Teva Pharm move closer to growth | Reuters
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
Jury holds drugmaker Teva liable in opioid crisis | WLUK
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.
AMC, Teva, launch coalition for equity through digital health
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
